FEBRUARY 2024LIFE SCIENCES REVIEW4CONTENTSCONTENTS12CO V ER S T O R YHOW CAN WE TACKLE THE HEALTH EQUITY GAP TO INNOVATIVE MEDICINES?SILVY MARDIGUIAN, PHD, SENIOR DIRECTOR, HEAD OF HEOR, EUROPE & NEW MARKETS,BEIGENEThe Broad and Current Interest of Pharmaceutical Industry: CFO's PerspectiveBruno Ruas, CFO, Tecnimede GroupIN MY OPINION08Drug Development for Rare DiseasesFabiana d'Aniello, PhD, R&D Portfolio Management Director, FerrerLAST WORD30
< Page 3 | Page 5 >